Radiosensitisation of Hepatocellular Carcinoma Cells by Vandetanib

Hepatocellular Carcinoma (HCC) is increasing in incidence worldwide and requires new approaches to therapy. The combination of anti-angiogenic drug therapy and radiotherapy is one promising new approach. The anti-angiogenic drug vandetanib is a tyrosine kinase inhibitor of vascular endothelial growt...

Descripción completa

Detalles Bibliográficos
Autores principales: Znati, Sami, Carter, Rebecca, Vasquez, Marcos, Westhorpe, Adam, Shahbakhti, Hassan, Prince, Jessica, Vlckova, Petra, De Vellis, Chiara, Bascal, Zainab, Loizidou, Marilena, Sharma, Ricky A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408860/
https://www.ncbi.nlm.nih.gov/pubmed/32668592
http://dx.doi.org/10.3390/cancers12071878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408860/
https://www.ncbi.nlm.nih.gov/pubmed/32668592
http://dx.doi.org/10.3390/cancers12071878

Ejemplares similares